Novavax (NVAX) PREVENT-19 results were submitted for publication
- Nasdaq, S&P 500 end lower, dragged down by communications services
- Intel (INTC) Stock Plummets as Expensive Investments Expected to Pressure Margins and FCF, Prompting Three Downgrades to Neutral
- Snap (SNAP) Stock Just Crashed 25% Following Earnings, Analyst Reaction Mixed
- Beyond Meat (BYND) Stock Plunges 14% After Slashing Revenue Outlook Amid a Decrease in Retail Orders
- Dollar pares losses as Powell signals bond taper
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Novavax (NASDAQ: NVAX) PREVENT-19 results were submitted for publication
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax (NVAX) Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality
- Agenus (AGEN) Withdraws Balstilimab BLA
- Achilles Therapeutics (ACHL) Presents Data ESGCT Congress Demonstrating its Proprietary Manufacturing Process Can Generate Potent, Personalized Anti-Cancer Cell Therapy Candidates in Multiple Solid Tu
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!